Dr. Martens PLC (DOCS)

London


	Symbol		Exchange		Currency
	DOCS		London		GBP	Real-time
	3U2		TradeGate		EUR	Delayed

Currency in GBP

Disclaimer

56.70

+0.60(+1.07%)

Real-time Data10:16:59

Fair Value

Day's Range

56.10

57.55

52 wk Range

49.42

140.00

DOCS Income Statement

Featured here, the Income Statement (earnings report) for Dr. Martens PLC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

31/03

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

Total Revenues

672.2

773

908.3

1,000.3

877.1

Total Revenues Growth

+47.93%

+15%

+17.5%

+10.13%

-12.32%

Cost Of Revenues

270.7

302.5

329.5

382.2

301.9

Gross Profit

401.5

470.5

578.8

618.1

575.2

Gross Profit Growth

+59.96%

+17.19%

+23.02%

+6.79%

-6.94%

Gross Profit Margin %

59.73%

60.87%

63.72%

61.79%

65.58%

Other Operating Expenses, Total

245.9

281.4

352.3

427.3

448.8

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+39.24%	+14.44%	+25.2%	+21.29%	+5.03%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	217	247.6	315.8	373.1	377.7
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-1.2

Operating Income

155.6

189.1

226.5

190.8

126.4

Operating Income Growth

+109.14%

+21.53%

+19.78%

-15.76%

-33.75%

EBIT Margin %

23.15%

24.46%

24.94%

19.07%

14.41%

Net Interest Expenses

-41.5

-41.6

-15.4

-16.8

-29.2

Net Interest Expenses Growth

-6.14%

-0.24%

+62.98%

-9.09%

-73.81%

Interest Expense, Total

-41.5

-41.6

-15.5

-18.7

-32.2

Interest And Investment Income

-

-

0.1

1.9

3

Other Non Operating Expenses, Total

-0.5

3.8

3.6

-10.7

-4.2

EBT, Excl. Unusual Items

113.6

151.3

214.7

163.3

93

Gain (Loss) On Sale Of Assets

-

-

-

-

-

Other Unusual Items, Total

-12.6

-81.6

-0.4

-3.9

-

EBT, Incl. Unusual Items

101

69.7

214.3

159.4

93

EBT, Incl. Unusual Items Growth

+249.48%

-30.99%

+207.46%

-25.62%

-41.66%

EBT, Incl. Unusual Items Margin

15.03

9.02

23.59

15.94

10.6

Income Tax Expense

26.2

35

33.1

30.5

23.8

Net Income to Company

74.8

34.7

181.2

128.9

69.2

Minority Interest

-

-

-

-

-

Net Income

74.8

34.7

181.2

128.9

69.2

Net Income Growth

+334.88%

-53.61%

+422.19%

-28.86%

-46.31%

Net Income Margin %

11.13%

4.49%

19.95%

12.89%

7.89%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

74.8

34.7

181.2

128.9

69.2

Basic EPS - Continuing Operations

0.07

0.03

0.18

0.13

0.07

Basic EPS - Continuing Operations Growth

+334.91%

-53.61%

+422.14%

-28.89%

-45.39%

Diluted EPS - Continuing Operations

0.07

0.03

0.18

0.13

0.07

Diluted EPS - Continuing Operations Growth

+334.91%

-53.61%

+421.61%

-28.82%

-45.67%

Basic Weighted Average Shares Outstanding

1,000

1,000

1,000.1

1,000.5

983.5

Diluted Weighted Average Shares Outstanding

1,000

1,000.4

1,002.9

1,001.2

985.6

Dividend Per Share

-

-

0.06

0.06

0.03

Dividend Per Share Growth

-

-

-

+6.18%

-56.34%

EBITDA

163.4

198.1

236

204.4

141.7

EBITDA Growth

+92.24%

+21.24%

+19.13%

-13.39%

-30.68%

EBITDA Margin %